182 related articles for article (PubMed ID: 20063399)
1. Skin cancer and Parkinson's disease.
Ferreira JJ; Neutel D; Mestre T; Coelho M; Rosa MM; Rascol O; Sampaio C
Mov Disord; 2010 Jan; 25(2):139-48. PubMed ID: 20063399
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease, levodopa-use and the risk of melanoma.
Vermeij JD; Winogrodzka A; Trip J; Weber WE
Parkinsonism Relat Disord; 2009 Sep; 15(8):551-3. PubMed ID: 19501540
[TBL] [Abstract][Full Text] [Related]
3. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
Zanetti R; Loria D; Rosso S
Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
[TBL] [Abstract][Full Text] [Related]
4. Treatment with levodopa and risk for malignant melanoma.
Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S
Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma and other types of cancer preceding Parkinson disease.
Olsen JH; Friis S; Frederiksen K
Epidemiology; 2006 Sep; 17(5):582-7. PubMed ID: 16837822
[TBL] [Abstract][Full Text] [Related]
6. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma in early Parkinson's disease: the DATATOP trial.
Constantinescu R; Romer M; Kieburtz K;
Mov Disord; 2007 Apr; 22(5):720-2. PubMed ID: 17373726
[TBL] [Abstract][Full Text] [Related]
8. [Melanoma while using levodopa due to Parkinson's disease--causal association unlikely].
Wobbes T; Bonenkamp JJ
Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1286-8. PubMed ID: 12138675
[TBL] [Abstract][Full Text] [Related]
9. The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers.
Inzelberg R; Israeli-Korn SD
J Neural Transm (Vienna); 2009 Nov; 116(11):1503-7. PubMed ID: 19789839
[TBL] [Abstract][Full Text] [Related]
10. On the role of aging in cancer incidence: analysis of the skin cancer data.
Ballou JA; Dix D
Anticancer Res; 1989; 9(4):1237-40. PubMed ID: 2817808
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
Pfützner W; Przybilla B
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
[TBL] [Abstract][Full Text] [Related]
12. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80.
Osterlind A; Olsen JH; Lynge E; Ewertz M
Natl Cancer Inst Monogr; 1985 Dec; 68():361-88. PubMed ID: 4088310
[TBL] [Abstract][Full Text] [Related]
13. StatBite: Cancer in patients with Parkinson's disease.
J Natl Cancer Inst; 2010 Mar; 102(6):373. PubMed ID: 20215592
[No Abstract] [Full Text] [Related]
14. Skin surveillance of a U.K. paediatric transplant population.
Thomson MA; Suggett NR; Nightingale PG; Milford DV; Baumann U; Kelly DA; Moss C; Hill VA
Br J Dermatol; 2007 Jan; 156(1):45-50. PubMed ID: 17199565
[TBL] [Abstract][Full Text] [Related]
15. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study.
Elbaz A; Peterson BJ; Bower JH; Yang P; Maraganore DM; McDonnell SK; Ahlskog JE; Rocca WA
Mov Disord; 2005 Jun; 20(6):719-25. PubMed ID: 15704188
[TBL] [Abstract][Full Text] [Related]
16. A Review of the Association Between Parkinson Disease and Malignant Melanoma.
Disse M; Reich H; Lee PK; Schram SS
Dermatol Surg; 2016 Feb; 42(2):141-6. PubMed ID: 26771684
[TBL] [Abstract][Full Text] [Related]
17. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
18. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
19. Incidence of skin cancer in 5356 patients following organ transplantation.
Lindelöf B; Sigurgeirsson B; Gäbel H; Stern RS
Br J Dermatol; 2000 Sep; 143(3):513-9. PubMed ID: 10971322
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
Chen JJ; Swope DM; Dashtipour K
Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
